Yan Xu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Interstitial Lung Disease

Ejection Fraction

Disease Activity

Rheumatoid Arthritis Patients

Top Venues

Immunity, inflammation and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Zhou, Wen Wang, Wenjia Gao, Yan Xu, Yinshan Zang
Fatigue in rheumatoid arthritis patients: The status, independent risk factors, and consistency of multiple scales. Immunity, inflammation and disease 12 (6) (2024)
Zhe Yu, Ling Gao, Yinshan Zang, Lu Cheng, Wenjia Gao, Yan Xu
Adalimumab exhibits superiority over etanercept in terms of a numerically higher response rate and equivalent adverse events: A real-world finding. Immunity, inflammation and disease 12 (2) (2024)
Jun Zhou, Wen Wang, Wenjia Gao, Yan Xu, Yinshan Zang
Fatigue in rheumatoid arthritis patients: The status, independent risk factors, and consistency of multiple scales. Immunity, inflammation and disease 12 (6) (2024)
Jun Zhou, Wen Wang, Wenjia Gao, Yan Xu, Yinshan Zang
Fatigue in rheumatoid arthritis patients: The status, independent risk factors, and consistency of multiple scales. Immunity, inflammation and disease 12 (6) (2024)
Zhe Yu, Ling Gao, Yinshan Zang, Lu Cheng, Wenjia Gao, Yan Xu
Adalimumab exhibits superiority over etanercept in terms of a numerically higher response rate and equivalent adverse events: A real-world finding. Immunity, inflammation and disease 12 (2) (2024)